← FDA DRUG APPROVALS

FDA ANDA · ANDA204923

OMEPRAZOLE AND SODIUM BICARBONATE

Sponsor: AUROBINDO PHARMA

APPLICATION
ANDA204923
TYPE
ANDA
ORIGINAL APPROVAL
2016-11-07
LATEST ACTION
2024-11-22
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Over-the-counter

Products

OMEPRAZOLE AND SODIUM BICARBONATEOver-the-counter
OMEPRAZOLE 20MG, SODIUM BICARBONATE 1.1GM · CAPSULE · ORAL

Approval history

2024-11-22Manufacturing (CMC) · Supplement 1 · unknownAP
2016-11-07UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →